miércoles, 2 de diciembre de 2009

Influenza A (H1N1) 2009 Monovalent Vaccines Composition and Lot Release


Influenza A (H1N1) 2009 Monovalent Vaccines Composition and Lot Release
The four manufacturers will make the Influenza A (H1N1) 2009 Monovalent vaccines using the established manufacturing processes for their seasonal influenza vaccines. FDA approved these vaccines as a strain change to each manufacturer’s seasonal influenza vaccine. There is considerable experience with seasonal influenza vaccine development and production and influenza vaccines produced by this technology have a long and successful track record of safety and effectiveness in the United States. The Influenza A (H1N1) 2009 Monovalent vaccines will undergo the usual testing and lot release procedures that are in place for seasonal influenza vaccines.


Lot release information will be updated weekly. Last update: 12/2/2009.

abrir aquí para acceder al documento FDA:
Influenza A (H1N1) 2009 Monovalent Vaccines Composition and Lot Release

No hay comentarios:

Publicar un comentario